.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Immunoglobulin light-chain amyloidosis represents a severe plasma cell dyscrasia characterized by extracellular deposition of misfolded light chain proteins across multiple organ systems. When light chains infiltrate myocardial tissue, patients develop AL cardiac amyloidosis, a rapidly progressive infiltrative cardiomyopathy associated with high mortality rates. Traditional non-invasive diagnostic strategies rely heavily on standard transthoracic echocardiography to detect structural alterations such as concentric ventricular thickening and diastolic dysfunction. However, standard left ventricular ejection fraction often remains preserved until advanced disease stages, failing to capture subtle myocardial injury early in the disease process. Consequently, clinicians require advanced imaging modalities to detect subclinical myocardial strain and refine patient risk stratification. Speckle-tracking echocardiography has transformed clinical assessment by providing quantitative measurements of myocardial deformation through regional longitudinal strain parameters. Furthermore, regional strain imaging allows cardiologists to evaluate differential segment impairment, distinguishing apical function from basal deformation. Understanding these early strain abnormalities is crucial for identifying high-risk individuals before overt heart failure develops. As therapeutic options for plasma cell dyscrasias expand, accurate early baseline prognostic tools become increasingly vital in clinical management.
The Japan Cardiac Amyloidosis Survey of typical Echocardiographic findings, known as the J-CASE survey, conducted a comprehensive multicenter retrospective study across 18 participating institutions in Japan. Investigators aimed to evaluate the exact prognostic impact of regional longitudinal strain parameters in patients diagnosed with AL cardiac amyloidosis. The broader registry enrolled 324 patients with histologically confirmed cardiac amyloidosis between the years 2000 and 2020. From this extensive cohort, researchers specifically identified and analyzed 81 patients with biopsy-proven light-chain disease who possessed complete two-dimensional speckle-tracking echocardiographic datasets. The median patient follow-up duration was 278 days, with an interquartile range spanning 63 to 1,133 days. During this observation period, 43 all-cause deaths occurred, reflecting the aggressive nature of untreated or advanced cardiac involvement. Researchers meticulously gathered baseline clinical demographic data, traditional echocardiographic indices, and segmental strain measurements. Specifically, two-dimensional strain analysis evaluated left ventricular basal, mid-ventricular, and apical regional longitudinal strain. By focusing on histologically validated cases, the study provided high-quality data regarding the association between speckle-tracking deformation patterns and long-term survival outcomes in clinical practice.
Multivariable survival analyses revealed that left ventricular apical longitudinal strain served as a significant and independent prognostic indicator in AL cardiac amyloidosis. Specifically, after adjusting for conventional echocardiographic findings such as ejection fraction and wall thickness, LV-apical strain retained a strong statistical association with all-cause mortality, yielding a hazard ratio of 0.86 (P < 0.05). Receiver operating characteristic curve analysis demonstrated an area under the curve of 0.68 for LV-apical strain in predicting overall mortality. The optimal cut-off value for LV-apical longitudinal strain was established at 15.9%, yielding a sensitivity of 71% and a specificity of 54%. Kaplan-Meier survival analysis further demonstrated a pronounced divergence in survival curves based on this threshold. Patients exhibiting low LV-apical longitudinal strain below 15.9% experienced significantly higher all-cause mortality compared to those maintaining higher strain values above 15.9% (log-rank test P < 0.05). These findings emphasize that apical deformation parameters provide superior prognostic discrimination compared to conventional metrics alone. Consequently, evaluating regional apical strain provides critical diagnostic value when risk-stratifying patients with infiltrative light-chain myocardial disease.
The preferential preservation of apical strain relative to basal strain—commonly referred to as apical sparing—is a hallmark echocardiographic pattern in cardiac amyloidosis. Amyloid fibril deposition typically exhibits a continuous gradient, accumulating more heavily in basal and mid-ventricular myocardial segments while relatively sparing the apex. Consequently, basal regional longitudinal strain deteriorates significantly earlier during disease progression. However, as amyloid burden increases, toxic light chains and structural amyloid infiltration eventually compromise apical myocardial fibers as well. Therefore, a decline in apical longitudinal strain indicates advanced, widespread myocardial infiltration and severe cellular injury. In addition, circulating free light chains exert direct cardiotoxic effects, inducing oxidative stress, microvascular dysfunction, and cardiomyocyte apoptosis. When apical strain drops below critical thresholds, it reflects widespread transmural involvement and severe loss of functional contractile reserves. As a result, assessing apical deformation provides direct insight into the total cumulative burden of amyloid toxicity. Incorporating regional longitudinal strain into routine echocardiographic protocols enables clinicians to detect transition points where localized infiltration converts into global mechanical failure.
Integrating regional longitudinal strain measurements into routine clinical workflows enhances existing prognostic models for light-chain amyloidosis. Currently, clinical risk stratification relies predominantly on biomarkers such as serum N-terminal pro-B-type natriuretic peptide, troponin T, and free light chain differentials. However, adding speckle-tracking echocardiography offers direct anatomical and functional insights into myocardial mechanical performance. By identifying patients with low LV-apical strain, clinicians can isolate individuals at elevated risk of immediate disease progression and cardiac death. This objective metric helps physicians tailor surveillance frequency and guide multidisciplinary treatment strategies effectively. Furthermore, accurate risk assessment facilitates timely initiation of disease-modifying therapies, including targeted anti-plasma cell regimens and novel fibril-directed therapeutics. Serial strain assessments may also monitor therapeutic response and detect subclinical cardiotoxicity during chemotherapy. Therefore, routine evaluation of regional longitudinal strain bridges the gap between biochemical staging and mechanical functional impairment. Ultimately, adopting comprehensive strain imaging improves clinical precision, guiding timely interventions that may prolong patient survival.
Although the J-CASE study provides compelling evidence, several methodological limitations warrant consideration during clinical interpretation. First, the retrospective study design inherently introduces potential selection biases and unmeasured confounding variables across participating centers. Second, the final cohort comprised 81 patients with AL amyloidosis, which represents a relatively modest sample size, albeit derived from a comprehensive multi-center Japanese registry. Third, inter-vendor variations in speckle-tracking software algorithms can introduce slight numerical discrepancies in regional strain measurements across different ultrasound platforms. Consequently, standardized strain imaging protocols remain crucial for consistent clinical application across institutions. Future prospective studies should investigate whether serial changes in LV-apical strain correlate directly with hematologic response and cardiac biomarker regression following systemic therapy. Additionally, combining regional longitudinal strain with advanced cardiac magnetic resonance imaging and extracellular volume mapping may further refine prognostic precision. Despite these limitations, the J-CASE survey robustly highlights LV-apical longitudinal strain as an essential prognostic marker in light-chain cardiac amyloidosis.
The primary finding from the J-CASE study is that left ventricular apical longitudinal strain serves as an independent predictor of all-cause mortality in AL cardiac amyloidosis. Specifically, patients with an LV-apical strain value below 15.9% faced a significantly higher risk of death. Even after adjusting for standard echocardiographic metrics, apical strain maintained independent prognostic power, highlighting its clinical utility in evaluating disease severity and identifying high-risk patients.
Left ventricular ejection fraction measures volumetric displacement and often remains within normal limits during early or mid-stage amyloidosis despite significant myocardial damage. Conversely, regional longitudinal strain directly quantifies subclinical myocardial fiber deformation using speckle-tracking technology. Consequently, strain imaging detects early mechanical dysfunction long before ejection fraction declines. Moreover, regional strain maps distinct patterns like apical sparing, offering both superior diagnostic sensitivity and reliable prognostic stratification.
Evaluating apical strain in plasma cell dyscrasias provides critical risk stratification, as cardiac amyloid involvement drives overall mortality. While basal strain deteriorates early in light-chain amyloidosis, preservation of apical strain produces relative apical sparing. When apical strain eventually deteriorates below 15.9%, it indicates severe, widespread myocardial infiltration. Identifying this transition helps clinicians optimize chemotherapy regimens, implement heart failure therapies promptly, and closely monitor high-risk individuals.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A multicenter J-CASE survey study reveals that left ventricular apical longitudinal strain (LV-apical LS) independently predicts all-cause death in patients with immunoglobulin light-chain (AL) cardiac amyloidosis, establishing an optimal prognostic cut-off threshold of 15.9%.
last month
A secondary analysis of an HIV cure-related trial in South Africa highlights the acceptability and safety of serial excisional lymph node and gut biopsies among young women. Clear communication, empathetic care, and altruistic motives helped mitigate initial apprehension and sustain longitudinal trial engagement.
Today
A nationwide study covering 3.7 million Swedish births reveals that prenatal exposure to TORCH pathogens significantly elevates long-term risks of intellectual disability and autism. Healthcare providers must recognize clinical indicators, promote prenatal prevention, and track early pediatric neurodevelopment.
Today
Under India's PLI initiative, domestic production of 57 critical medical devices has commenced, including MRI and CT scanners, cath labs, and heart valves. Global partnerships and local investments are expanding high-end technology, curbing import reliance, and strengthening clinical accessibility nationwide.
Today
A longitudinal study reveals that patients undergoing staged bilateral hip arthroscopy experience progressive contralateral labral deterioration during surgical intervals. However, structural degradation does not compromise 2-year postoperative clinical outcomes or patient-reported satisfaction scores.
Today
New immunological research reveals how PTPN22 forms a delayed inhibitory signaling complex to restrain T cell activation, explaining how the autoimmune-linked R620W variant disrupts feedback control and promotes persistent inflammation in conditions like rheumatoid arthritis and type 1 diabetes.
Today
